Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study

PEP‐C (prednisolone, etoposide, procarbazine and cyclophosphamide) is an orally administered daily chemotherapy regimen used with palliative intent in relapsed refractory lymphoma. To our knowledge, no data on PEP‐C have been reported since the original group described the regimen. Here we present a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bulley, Simon J., Santarsieri, Anna, Lentell, Isabel C., O'Sullivan, Brendan, Hodson, Andrew, Firth, Oliver, Sadullah, Shalal, Follows, Annabel M., Karanth, Mamatha, Min, Sandra Young, Fowler, Alexis, Russell, James, Uttenthal, Benjamin J., Hodson, Daniel J., Follows, George A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713053/
https://www.ncbi.nlm.nih.gov/pubmed/36467809
http://dx.doi.org/10.1002/jha2.537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713053/
https://www.ncbi.nlm.nih.gov/pubmed/36467809
http://dx.doi.org/10.1002/jha2.537

Ejemplares similares